Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a monoclonal antibody therapy for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED